Latest filing published 11 Sept 2026 for AtaiBeckley Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Srinivas Rao, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in ATAI Life Sciences N.V. and AtaiBeckley Inc. The record holds 7 filings, for trades running from 22 June 2021 to 11 September 2026.
On the open market, the record shows 1 purchase worth €44k and 2 sales worth €200k. On balance, insiders were net sellers of €156k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises.
The newest entry dates from 11 September 2026: a transaction, in AtaiBeckley Inc. The last purchase on record was published on 24 June 2021, which is 1,942 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations